Financials
- Market Capitalization 351.68 M
- Employee 9
- Founded 2000
- CEO N/A
- Website www.galectintherapeutics.com
- Headquarter Nevada, United States
- FIGI BBG000BK6FP5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-8.67
Fiyat/satışlar oranı
-74.93
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3174 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.62 USD | -0.65% | -3.95% | -2.12% | +11.06% | 362.77 M USD | ||
| 3196 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.85 USD | -2.50% | -8.59% | -0.51% | +5.79% | 351.79 M USD | ||
| 3206 | PRLD Prelude Therapeutics Incorporated - Common Stock | 4.39 USD | -1.13% | -11.49% | +0.46% | +441.98% | 349.64 M USD | ||
| 3210 | FATE Fate Therapeutics, Inc. - Common Stock | 2.99 USD | -0.99% | +2.40% | +47.29% | +162.28% | 348.51 M USD |